Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
The original version of the published Article contained an incorrect citation for reference 20 “Hubbard, B. P. & Sinclair, D. A. Measurement of sirtuin enzyme activity using a substrate-agnostic fluorometric nicotinamide assay. Methods Mol. Biol. 1077, 167–177 (2013).” The citation for reference...
Enregistré dans:
Auteurs principaux: | Ryan W. Dellinger, Santiago Roel Santos, Mark Morris, Mal Evans, Dan Alminana, Leonard Guarente, Eric Marcotulli |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4ad9d9e6d3a4470ca37aec031a9b1b39 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
par: Ryan W. Dellinger, et autres
Publié: (2017) -
Nicotinamide riboside kinase structures reveal new pathways to NAD+.
par: Wolfram Tempel, et autres
Publié: (2007) -
NAD+ augmentation with nicotinamide riboside improves lymphoid potential of Atm −/− and old mice HSCs
par: Le Zong, et autres
Publié: (2021) -
Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
par: Samuel A. J. Trammell, et autres
Publié: (2016) -
Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults
par: Christopher R. Martens, et autres
Publié: (2018)